


IRIS to Release Fourth Quarter and Year-End 2008 Financial Results and Host Conference Call on February 18, 2009
CHATSWORTH, Calif.--([ BUSINESS WIRE ])--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), will hold a conference call to discuss fourth quarter and year-end 2008 financial results on Wednesday, February 18, 2009, at 4:30 p.m. Eastern Time. César García, Chairman, President and Chief Executive Officer, and members of his senior staff will review the Company's results, which will be released at the close of trading that day.
To participate, dial 1- 888-259-8843 approximately 10 minutes before the conference call is scheduled to begin. Hold for the operator and reference the IRIS International conference call. International callers should dial 913-981-5530.
The conference call may also be accessed by means of a live Web cast on the Company's website at [ www.proiris.com ], or at [ www.vcall.com ], the web cast service provider. The conference audio cast will also be available for replay on both web sites for 30 days from the date of the broadcast.
Access to the recording will also be available for seven days following the conference call. Dial 1-888- 203-1112 to access playback. For international callers, dial 719-457-0820. The pass code I.D. is 3492293.
About IRIS International
IRIS International, Inc., ([ www.proiris.com ]) is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The Company's products leverage its strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial applications for its technology have been in the urinalysis market and the Company is the leading worldwide provider of urine microscopy systems, with an installed based of more than 2100 systems in over 50 countries.